United States · FDA National Drug Code directory

Degex Liquescence

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 83027-0154_f6532279-4150-4a3d-b6c8-7b9764160b80
Product NDC: 83027-0154
Form: LIQUID
Composition / generic term: Thuja Occidentalis, Ubidecarenonum, Conium Maculatum, Asterias Rubens, Germanium Metallicum, Lachesis Mutus, Bufo Rana, Carcinosin, Phosphorus
Labeler: Nutritional Specialties, Inc.
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 20250923
Source listing expiry: 20261231

Source-listed ingredients

THUJA OCCIDENTALIS LEAFY TWIG — 6 [hp_X]/mL
UBIDECARENONE — 8 [hp_X]/mL
CONIUM MACULATUM FLOWERING TOP — 9 [hp_X]/mL
ASTERIAS RUBENS — 12 [hp_X]/mL
GERMANIUM — 15 [hp_X]/mL
LACHESIS MUTA VENOM — 12 [hp_X]/mL
BUFO BUFO CUTANEOUS GLAND — 15 [hp_X]/mL
HUMAN BREAST TUMOR CELL — 16 [hp_X]/mL
PHOSPHORUS — 30 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

120 mL in 1 BOTTLE, GLASS (83027-0154-1) · 83027-0154-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →